Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Turmoil Keeps Spotlight on Its Commissioner

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership of Dr. Marty Makary.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Appointments and Executive Changes, Centers for Disease Control and Prevention, Drugs (Pharmaceuticals), Food and Drug Administration, Government Employees, Health and Human Services Department, Kennedy, Robert F Jr, Makary, Marty, Rare and Orphan Diseases, Regulation and Deregulation of Industry, Trump, Donald J, United States Politics and Government
←Want to Know Where the Market Is Going? Don’t Trust This, or Any, Forecast.
52 Places to Go, So Little Time: Where We Went in 2025→

More posts

  • How Uruguay built a national care system from the ground up

  • Ask Jordan: What can Congress do about gerrymandering that the Supreme Court would allow?

  • South Korea catches 111 students with new measures against exam cheating

  • Cummins retains Cricket Australia support as captain

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube